MX2018013499A - Modulacion del metabolismo lipidico para la produccion de proteinas. - Google Patents

Modulacion del metabolismo lipidico para la produccion de proteinas.

Info

Publication number
MX2018013499A
MX2018013499A MX2018013499A MX2018013499A MX2018013499A MX 2018013499 A MX2018013499 A MX 2018013499A MX 2018013499 A MX2018013499 A MX 2018013499A MX 2018013499 A MX2018013499 A MX 2018013499A MX 2018013499 A MX2018013499 A MX 2018013499A
Authority
MX
Mexico
Prior art keywords
lipid metabolism
modulation
cells
protein production
cell
Prior art date
Application number
MX2018013499A
Other languages
English (en)
Spanish (es)
Inventor
Young Robert
Budge James
Mark Smales Christopher
Knight Tanya
Original Assignee
Lonza Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza Ag filed Critical Lonza Ag
Publication of MX2018013499A publication Critical patent/MX2018013499A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0681Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0682Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0071Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0071Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0083Miscellaneous (1.14.99)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0097Oxidoreductases (1.) acting on reduced flavodoxin as donor (1.19)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y114/00Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/19Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water (1.14.19)
    • C12Y114/19001Stearoyl-CoA 9-desaturase (1.14.19.1), i.e. DELTA9-desaturase
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Reproductive Health (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
MX2018013499A 2016-05-03 2017-05-03 Modulacion del metabolismo lipidico para la produccion de proteinas. MX2018013499A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662330973P 2016-05-03 2016-05-03
PCT/EP2017/060484 WO2017191165A1 (en) 2016-05-03 2017-05-03 Modulation of lipid metabolism for protein production

Publications (1)

Publication Number Publication Date
MX2018013499A true MX2018013499A (es) 2019-09-11

Family

ID=58745198

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018013499A MX2018013499A (es) 2016-05-03 2017-05-03 Modulacion del metabolismo lipidico para la produccion de proteinas.

Country Status (13)

Country Link
US (3) US10655111B2 (enExample)
EP (1) EP3452608B1 (enExample)
JP (1) JP6959942B2 (enExample)
KR (1) KR102536221B1 (enExample)
CN (1) CN109415748A (enExample)
AU (1) AU2017259010B2 (enExample)
CA (1) CA3023038C (enExample)
EA (1) EA201892503A1 (enExample)
ES (1) ES2938626T3 (enExample)
IL (2) IL294241B2 (enExample)
MX (1) MX2018013499A (enExample)
SG (1) SG11201809626PA (enExample)
WO (1) WO2017191165A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6959942B2 (ja) 2016-05-03 2021-11-05 ロンザ リミテッドLonza Limited タンパク質生成のための脂質代謝のモジュレーション
WO2020014483A1 (en) * 2018-07-11 2020-01-16 Cornell University Supported plant plasma membrane lipid bilayer on-a-chip
IL280880B2 (en) 2018-08-27 2025-04-01 Regeneron Pharma Using Raman Spectroscopy in Downstream Purification
US12331320B2 (en) 2018-10-10 2025-06-17 The Research Foundation For The State University Of New York Genome edited cancer cell vaccines
WO2020084528A1 (en) * 2018-10-24 2020-04-30 Selexis Sa Expression systems, recombinant cells and uses thereof
US11504390B2 (en) 2019-03-20 2022-11-22 Regeneron Pharmaceuticals, Inc. Treatment of increased lipid levels with sterol regulatory element binding transcription factor 1 (SREBF1) inhibitors
CN110317799A (zh) * 2019-07-18 2019-10-11 江南大学 一种人源岩藻糖转移酶8的原核表达方法及其产品
KR20220097910A (ko) 2019-11-14 2022-07-08 론자 리미티드 세포 선택 방법
CN115029307A (zh) * 2022-07-28 2022-09-09 吉林大学 一种延缓MSCs衰老的方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9022545D0 (en) 1990-10-17 1990-11-28 Wellcome Found Culture medium
EP0985039B1 (en) 1997-06-12 2008-02-20 Novartis International Pharmaceutical Ltd. Artificial antibody polypeptides
HK1047109A1 (zh) 1999-10-15 2003-02-07 University Of Massachusetts 作为指定基因干预工具的rna干预轨迹基因
US6326193B1 (en) 1999-11-05 2001-12-04 Cambria Biosciences, Llc Insect control agent
AU2001275474A1 (en) 2000-06-12 2001-12-24 Akkadix Corporation Materials and methods for the control of nematodes
WO2002095008A2 (en) * 2001-02-02 2002-11-28 Bayer Corporation Methods of modulating surfactant phospholipid production
AU2004248165A1 (en) * 2003-06-11 2004-12-23 Biogen Idec Ma Inc. Method to increase protein production in culture
CN102286483B (zh) 2004-04-16 2014-06-04 中化帝斯曼制药有限公司荷兰公司 用于在真菌细胞中表达基因的真菌启动子
CA2606576A1 (en) * 2005-05-20 2006-11-23 Lonza Biologics Plc. High-level expression of recombinant antibody in a mammalian host cell
US20080182249A1 (en) * 2006-09-01 2008-07-31 Fox Brian G Expression systems for mammalian and mycobacterial desaturases
US20110281301A1 (en) * 2007-11-13 2011-11-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg The secretory capacity in host cells
CA3015426C (en) * 2008-11-18 2020-01-14 Commonwealth Scientific And Industrial Research Organisation Recombinant cells comprising exogenous .delta.5 and .delta.6 desaturases, .delta.5 and .delta.6 elongases, and .delta.4 desaturases
ES2717175T3 (es) * 2013-02-01 2019-06-19 Selexis Sa Expresión mejorada de transgenes y procesamiento
CN105849265B (zh) * 2013-08-06 2021-03-26 英国龙沙生物医药股份有限公司 用于产生供生产重组蛋白的哺乳动物生产细胞的物品和方法
JP6959942B2 (ja) 2016-05-03 2021-11-05 ロンザ リミテッドLonza Limited タンパク質生成のための脂質代謝のモジュレーション

Also Published As

Publication number Publication date
BR112018072434A2 (pt) 2019-02-19
JP2019514399A (ja) 2019-06-06
US20200231944A1 (en) 2020-07-23
KR20190003651A (ko) 2019-01-09
US10655111B2 (en) 2020-05-19
CA3023038C (en) 2023-03-14
IL262646B (en) 2022-08-01
EP3452608A1 (en) 2019-03-13
WO2017191165A1 (en) 2017-11-09
CN109415748A (zh) 2019-03-01
IL294241A (en) 2022-08-01
JP6959942B2 (ja) 2021-11-05
IL294241B2 (en) 2023-10-01
ES2938626T3 (es) 2023-04-13
US11434474B2 (en) 2022-09-06
IL294241B1 (en) 2023-06-01
AU2017259010A1 (en) 2018-11-22
IL262646A (en) 2018-12-31
SG11201809626PA (en) 2018-11-29
EP3452608B1 (en) 2022-11-30
CA3023038A1 (en) 2017-11-09
US20230047838A1 (en) 2023-02-16
AU2017259010B2 (en) 2021-04-22
US20170321194A1 (en) 2017-11-09
KR102536221B1 (ko) 2023-05-23
EA201892503A1 (ru) 2019-09-30

Similar Documents

Publication Publication Date Title
MX2018013499A (es) Modulacion del metabolismo lipidico para la produccion de proteinas.
AU2018271755A1 (en) Method for culturing natural killer cell, using transformed T cell
SG10201810830UA (en) Cell culture compositions and methods for polypeptide production
MY208943A (en) Taurine supplemented cell culture medium and methods of use
MX2024012982A (es) Metodos para la generacion de celulas-t a partir de celulas madre y metodos inmunoterapeuticos que utilizan las celulas-t
SG10201809452RA (en) Cell culture compositions with antioxidants and methods for polypeptide production
WO2019014310A8 (en) Biological methods for preparing terpenes
WO2014116846A3 (en) Methods and compositions for modulating an immune response
MY192824A (en) Compound targeting il-23a and tnf-alpha and uses thereof
MX2016001986A (es) Metodo para preparar rebaudiosido m mediante el uso de un metodo con enzima.
WO2015051342A3 (en) Compositions and methods for modulating biomass productivity
MX2016009149A (es) Variantes mejoradas de enzimas.
MX2018015298A (es) Metodo para estabilizar proteinas.
AU2016250905A8 (en) Generation of muscle-lineage cells from stem cells
PH12019501001A1 (en) Method for preparing electrocompetent yeast cells, and method for using said cells
WO2019094447A8 (en) Production of mycosporine-like amino acids in cyanobacteria
WO2015187825A3 (en) Compositions and methods for modulating dysferlin expression
HK1247958A1 (zh) T淋巴细胞的调节
EP4446338A3 (en) Cells and method of cell culture
EP4332231A3 (en) Novel vertebrate cells and methods for recombinantly expressing a polypeptide of interest
MX2015000188A (es) Metodo para producir iduronato-2-sulfatasa recombinante.
WO2020205626A8 (en) Modulators of cell surface protein interactions and methods and compositions related to same
WO2018053507A3 (en) Production of sesquiterpene products and related molecules
WO2021016227A8 (en) Synthetic genetic elements for biomanufacture
MX2022000516A (es) Metodos relacionados con celulas pluripotentes.